ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
From - Laboratory Industry Report
Quest Diagnostics has received emergency clearance from the U.S. Food and Drug Administration to distribute its molecular assay for…
From - Laboratory Industry Report
Florida-based Aurora Diagnostics has acquired another pathology practice, this one located in the central part of the Sunshine State. Aurora announced…